ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.260,90
0,00%
S&P 500
5.872,16
-2,95%
Dow Jones
42.326,87
-2,58%
Euro vs US Dollar
1,0397
0,45%
Bitcoin
101.362,90
1,30%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Australien
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) News

DNA

Donaco (DNA)

Donaco International Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:ASX:DNA
DatumZeitQuelleÜberschriftSymbolFirma
11/11/201500h52The Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
27/03/200916h13Dow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
27/03/200915h35Dow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
26/03/200910h23Dow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverNYSE:DNAGenentech Inc.
26/03/200908h05Dow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%NYSE:DNAGenentech Inc.
26/03/200907h37Dow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%NYSE:DNAGenentech Inc.
25/03/200913h44Dow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanNYSE:DNAGenentech Inc.
25/03/200911h43Dow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMNYSE:DNAGenentech Inc.
24/03/200919h08Dow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareNYSE:DNAGenentech Inc.
19/03/200918h09Dow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTNYSE:DNAGenentech Inc.
18/03/200914h55Dow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpNYSE:DNAGenentech Inc.
18/03/200908h16Dow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerNYSE:DNAGenentech Inc.
18/03/200907h33Dow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerNYSE:DNAGenentech Inc.
18/03/200905h32Dow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackNYSE:DNAGenentech Inc.
18/03/200902h05Dow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsNYSE:DNAGenentech Inc.
17/03/200923h54Dow Jones NewsBiotechnology Group Praises Biologic Drugs BillNYSE:DNAGenentech Inc.
17/03/200921h29Dow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200920h25Dow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200918h53Dow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200918h01Dow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200917h13Dow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
16/03/200921h57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200919h49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200907h37Dow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionNYSE:DNAGenentech Inc.
13/03/200913h45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200921h42Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200920h15Dow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersNYSE:DNAGenentech Inc.
12/03/200915h06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNYSE:DNAGenentech Inc.
12/03/200912h10Dow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200909h32Dow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
COIN
DOGEUSD
Dogecoin
NYSE
MRK
Merck
TG
D7G
Nel ASA
NASDAQ
TSLA
Tesla
FX
EURJPY
Euro vs Yen
TG
BAYN
Bayer
TG
432
Arbor Metals
AMEX
SPY
SPDR S&P 500
USOTC
BNPQY
BNP Paribas (QX)
COIN
ETHUSD
Ethereum
TG
NOV
Novo Nordisk
CCOM
US30
US 30
TG
DBK
Deutsche Bank
USOTC
ADDYY
Adidas (QX)
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten